EKGG.F Stock Overview
Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CardioComm Solutions, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.013 |
| 52 Week High | CA$0.015 |
| 52 Week Low | CA$0.0006 |
| Beta | -0.14 |
| 11 Month Change | 16.67% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -50.31% |
| 5 Year Change | -60.28% |
| Change since IPO | -96.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| EKGG.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 6.6% | 5.0% |
| 1Y | n/a | 17.8% | 36.1% |
Return vs Industry: Insufficient data to determine how EKGG.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how EKGG.F performed against the US Market.
Price Volatility
| EKGG.F volatility | |
|---|---|
| EKGG.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: EKGG.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine EKGG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Etienne Grima | cardiocommsolutions.com |
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. It offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat – Mobile ECG device, and HeartCheck SMART monitoring. The company also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L.
CardioComm Solutions, Inc. Fundamentals Summary
| EKGG.F fundamental statistics | |
|---|---|
| Market cap | US$2.78m |
| Earnings (TTM) | -US$101.39k |
| Revenue (TTM) | US$462.14k |
6.0x
P/S Ratio-27.4x
P/E RatioIs EKGG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKGG.F income statement (TTM) | |
|---|---|
| Revenue | CA$643.06k |
| Cost of Revenue | CA$39.56k |
| Gross Profit | CA$603.50k |
| Other Expenses | CA$744.58k |
| Earnings | -CA$141.09k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00073 |
| Gross Margin | 93.85% |
| Net Profit Margin | -21.94% |
| Debt/Equity Ratio | -75.2% |
How did EKGG.F perform over the long term?
See historical performance and comparison